Literature DB >> 2786443

Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.

J D Salamone1, R W Keller, M J Zigmond, E M Stricker.   

Abstract

The dialysis perfusion method was used to study the effects of haloperidol, electrical brain stimulation, and behavioral activation on extracellular levels of dopamine metabolites in the rat striatum. Systemic administration of 0.2 mg/kg haloperidol increased extracellular levels of the metabolites homovanillic acid (HVA) and dihydroxyphenylacetic acid (DOPAC) by 2-3-fold. Electrical stimulation of the medial forebrain bundle also increased HVA levels in dialysis perfusates. Rats pressing a lever for food reward showed 10-40% increases in HVA and DOPAC levels that reached a maximum 30-120 min after the behavioral session. The magnitude of the increases in HVA levels were correlated with the number of lever press responses. Presentation of a single 45-mg food pellet every 30 s to food-deprived rats produced a variety of motor activities and also increased the concentration of extracellular HVA. The results of the behavioral experiments indicate that striatal dopamine neurons are activated during conditions that increase motor activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786443     DOI: 10.1016/0006-8993(89)90826-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes.

Authors:  J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Changes in the amounts of neurotransmitters released from the striatum and spontaneous motor activity in rats exposed to high doses of toluene.

Authors:  H Aikawa; T Yoshida; S Shigeta
Journal:  Environ Health Prev Med       Date:  1997-01       Impact factor: 3.674

3.  Individual differences in dopamine efflux in nucleus accumbens shell and core during instrumental learning.

Authors:  Jingjun Cheng; Matthijs G P Feenstra
Journal:  Learn Mem       Date:  2006 Mar-Apr       Impact factor: 2.460

Review 4.  Does the difference between physically active and couch potato lie in the dopamine system?

Authors:  Amy M Knab; J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2010-03-09       Impact factor: 6.580

5.  Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2008-11-17       Impact factor: 3.533

6.  Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-08-31       Impact factor: 3.533

7.  Effects of a single haloperidol application to neonatal and early postnatal rats on the neurotransmitter content in the corpus striatum.

Authors:  R Schwabe; R Thiel; I Chahoud; D Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Halothane anesthesia affects NMDA-stimulated cholinergic and GABAergic modulation of striatal dopamine efflux and metabolism in the rat in vivo.

Authors:  K J Whitehead; S Rose; P Jenner
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

9.  Effects of intrinsic aerobic capacity and ovariectomy on voluntary wheel running and nucleus accumbens dopamine receptor gene expression.

Authors:  Young-Min Park; Jill A Kanaley; Jaume Padilla; Terese Zidon; Rebecca J Welly; Matthew J Will; Steven L Britton; Lauren G Koch; Gregory N Ruegsegger; Frank W Booth; John P Thyfault; Victoria J Vieira-Potter
Journal:  Physiol Behav       Date:  2016-06-11

10.  Dopamine agonists facilitate footshock-elicited locomotion in rats, and suppress level-press responding for food.

Authors:  S R Franklin; A H Tang
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.